EUVIMEDEUVIMED entdecken
Open Access

Prevalence and Significance of Pancreatic Iron in Transfusion‐Dependent Sickle Cell Disease

Akhila Vadivelan iD, Eamon Doyle, Susan Carson, Christopher Denton, Saranya Veluswamy, Thomas Hofstra, Thomas Coates, John C Wood iD

Pediatric Blood & Cancer · 2025

DOI: 10.1002/pbc.31780 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Akhila Vadivelan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Pediatric Hematology/Oncology, UCLA Mattel Children's Hospital, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Iron Overload, beta-Thalassemia, Pancreas. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCATS NIH HHS, Philips Medical Systems.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronically transfused patients with sickle cell disease (SCD) and beta thalassemia major (TM) develop iron overload.

Objective

Determine the impact of iron overload on glucose regulation in SCD.

Methods

Prospective study of 28 patients with SCD and 38 patients with TM who underwent liver and pancreas R 2 * measurements and oral glucose tolerance tests.

Results

Impaired fasting glucose (2 vs. 9, p = 0.27) and impaired glucose tolerance (1 vs. 11, p = 0.019) were less common in patients with SCD compared with patients with TM. No SCD patient had diabetes.

Conclusion

Iron‐mediated glucose dysregulation is present but less common in SCD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellIron Overloadbeta-ThalassemiaPancreasIronTransfusion ReactionHumansMaleFemaleChildAdolescentProspective StudiesPrevalenceGlucose Tolerance TestBlood TransfusionAdultYoung AdultBlood GlucoseChild, Preschool

Stichwörter der Autor:innen

pancreatic siderosissickle cell diseasetransfusion dependent

Substanzen

IronBlood Glucose

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Pediatric Hematology/Oncology, UCLA Mattel Children's Hospital, Los Angeles, California, USA.
  • Department of Clinical Radiology, USC Keck School of Medicine, Children's Hospital of Los Angeles, Los Angeles, California, USA.
  • Department of Pediatrics, Cancer and Blood Disease Institute, Section of Hematology, USC Keck School of Medicine, Children's Hospital of Los Angeles, Los Angeles, California, USA.
  • Department of Pediatrics, Division of Cardiology, USC Keck School of Medicine, Children's Hospital of Los Angeles, Los Angeles, California, USA.

ORCID-Profile: Akhila Vadivelan, John C Wood

Förderung

  • NIDDK NIH HHS
  • NCATS NIH HHS
  • Philips Medical Systems
  • Saban Research Institute

Zitieren

APA

Vadivelan, A., Doyle, E., Carson, S., Denton, C., Veluswamy, S., Hofstra, T., Coates, T., & Wood, J. C. (2025). Prevalence and Significance of Pancreatic Iron in Transfusion‐Dependent Sickle Cell Disease. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31780

Vancouver

Vadivelan A, Doyle E, Carson S, Denton C, Veluswamy S, Hofstra T, et al. Prevalence and Significance of Pancreatic Iron in Transfusion‐Dependent Sickle Cell Disease. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31780

BibTeX
@article{Vadivelan2025,
  author = {Vadivelan, Akhila and Doyle, Eamon and Carson, Susan and Denton, Christopher and Veluswamy, Saranya and Hofstra, Thomas and Coates, Thomas and Wood, John C},
  title = {Prevalence and Significance of Pancreatic Iron in Transfusion‐Dependent Sickle Cell Disease},
  journal = {Pediatric Blood & Cancer},
  year = {2025},
  doi = {10.1002/pbc.31780}
}
Kostenlos starten →